Register for email alerts and news feeds:
This journal | BMJ Group
rss
Thorax 2002;57:897-901; doi:10.1136/thorax.57.10.897
Copyright © 2002 BMJ Publishing Group Ltd & British Thoracic Society.
Thorax 2002;57:897-901
© 2002 Thorax

ORIGINAL ARTICLE

Apoptosis resistant bronchoalveolar lavage (BAL) fluid lymphocytes in sarcoidosis

H Stridh1, A Planck1, D Gigliotti2, A Eklund1, J Grunewald1

1 Department of Medicine, Division of Respiratory Medicine, Karolinska Institutet, Stockholm, Sweden
2 Department of Microbiology and Tumorbiology Centre and Department of Microbiology, Pathology and Immunology, Division of Biomedical Laboratory Technology, Karolinska Institutet

Correspondence to:
Correspondence to:
Dr H Stridh, Department of Medicine, Division of Respiratory Medicine, Karolinska Institutet, 171 77, Stockholm, Sweden;
helene.stridh{at}ks.se

Background: Sarcoidosis is a chronic granulomatous lung disease of unknown origin. The accumulation of activated T cells at sites of inflammation represents an early stage in granuloma formation. Since mechanisms governing the normal resolution of inflammatory processes are poorly understood, this study aimed to investigate the apoptotic phenotype of peripheral blood and lung T lymphocytes from patients with sarcoidosis.

Methods: Bronchoalveolar lavage (BAL) was performed in 10 patients with active sarcoidosis and five healthy controls.

Results: Virtually no lymphocyte apoptosis, as determined by annexin V or Hoechst staining, was seen in either patients or controls. Sustained caspase-3 activity in non-apoptotic BAL fluid lymphocytes of the patients was detected, however, in agreement with in vitro studies demonstrating caspase activation after T cell receptor (TCR) triggering as a physiological response required for efficient T cell activation. Only 11.0% (range 7.7–17.6) of the BAL lymphocytes from sarcoidosis patients were annexin V positive after exposure to the apoptotic stimulus tributyltin compared with 55.0% (range 42.0–62.0) of BAL lymphocytes from healthy controls (p<0.001). After anti-Fas treatment only 8.5% (range 6–10) of BAL fluid lymphocytes from patients but 45.5% (range 38–62) from healthy controls were apoptotic.

Conclusion: BAL fluid lymphocytes from patients with sarcoidosis display a non-apoptotic morphology associated with endogenous caspase-3 activity. They seem to be resistant to apoptosis, which might contribute to the accumulation of inflammatory cells in the lungs, persistence of inflammation, and the development and maintenance of granuloma.

Keywords: apoptosis; sarcoidosis; lymphocytes


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Muller, M., Grunewald, J., Olgart Hoglund, C., Dahlen, B., Eklund, A., Stridh, H. (2006). Altered apoptosis in bronchoalveolar lavage lymphocytes after allergen exposure of atopic asthmatic subjects. Eur Respir J 28: 513-522 [Abstract] [Full Text]  
  • Sawyer, R. T., Day, B. J., Fadok, V. A., Chiarappa-Zucca, M., Maier, L. A., Fontenot, A. P., Silveira, L., Newman, L. S. (2004). Beryllium-Ferritin: Lymphocyte Proliferation and Macrophage Apoptosis in Chronic Beryllium Disease. Am. J. Respir. Cell Mol. Bio. 31: 470-477 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Chest Medicine Jobs

Chest Medicine Jobs